Recent Press Releases

Meda to acquire Rottapharm, creating a European specialty pharma leader

Meda to acquire Rottapharm, creating a European specialty pharma leader GÖTEBORG, Sweden--(Business Wire)--Regulatory News: Meda (STO:MEDAA): The combined entity will have enhanced scale, reach...

Dendreon Names W. Thomas Amick President and Chief Executive Officer

SEATTLE, Jul 30, 2014 (BUSINESS WIRE) -- Dendreon Corporation DNDN -0.71% today announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer,...

New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015

(Washington, D.C.)—New high priced hepatitis C drugs will increase federal spending in Medicare Part D by a projected $2.9 to $5.8 billion next year, according to a new report by the actuarial...

COVINGTON ADVISES ASTRAZENECA ON STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE

COVINGTON ADVISES ASTRAZENECA ON STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE 7/30/2014 LONDON, 30 July, 2014 — Covington & Burling advised AstraZeneca on its agreement to...

Teva Reports Second Quarter 2014 Results

Teva Reports Second Quarter 2014 Results Revenues of $5.0 billion, up 2% compared to the second quarter of 2013. Non GAAP operating income of $1.4 billion, an increase of 8%. GAAP operating income...

Dendreon Names W. Thomas Amick President and Chief Executive Officer

Dendreon Names W. Thomas Amick President and Chief Executive Officer SEATTLE, Jul 30, 2014 (BUSINESS WIRE) -- Dendreon Corporation DNDN 0.00% today announced that its board of directors has...

AstraZeneca PLC SECOND QUARTER AND HALF YEAR RESULTS 2014

AstraZeneca PLC SECOND QUARTER AND HALF YEAR RESULTS 2014 Revenue in the second quarter was $6,454 million, up 4%* - second consecutive quarter of revenue growth. Half year revenue up 3%, driven by...

AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014

AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014 Record Physician Demand Drives 27% Increase in U.S. Net Feraheme...

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

DEERFIELD, Ill., July 30, 2014 - Baxter International Inc. (NYSE:BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related...

Pfizer Enters Into Agreement To Acquire Baxter's Portfolio Of Marketed Vaccines

Wednesday, July 30, 2014 - 8:00am EDT Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.'s portfolio of marketed vaccines for...

ASTRAZENECA AGREES STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE

ASTRAZENECA AGREES STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE Business combination will provide boost to revenue as well as creating long-term value, strengthening AstraZeneca's...

Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37

Second Quarter 2014 GAAP EPS Were $2.01

THOUSAND OAKS, Calif., July 29, 2014 /PRNewswire/ -- Amgen (

Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo

Company's two-booth approach allows customers to see how Roche is partnering with them today and tomorrow

CHICAGO,

GSK's Tanzeum™ is now available in pharmacies in the U.S.

PHILADELPHIA, July 29, 2014 /PRNewswire/ -- GSK (LSE/NYSE: GSK) today announced that once-weekly Tanzeum (alb

Roche's Gazyvaro approved in Europe for patients with the most common type of leukemia

Roche's Gazyvaro approved in Europe for patients with the most common type of leukemia Gazyvaro, the first type II, glycoengineered anti-CD20 monoclonal antibody is now approved in Europe for...

Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo

ABBOTT PARK, Ill., July 28, 2014 /PRNewswire/ -- Clinical laboratories around the world are helping to improve patient care while navigat

Physician and Industry Groups to Discuss Sunshine Act Implementation

Physician and Industry Groups to Discuss Sunshine Act Implementation WASHINGTON, D.C. — The American Association of Neurological Surgeons (AANS) and the Pharmaceutical Research and...

ASTRAZENECA AND ROCHE ANNOUNCE PARTNERSHIP TO DEVELOP COMPANION DIAGNOSTIC TEST FOR AZD9291

ASTRAZENECA AND ROCHE ANNOUNCE PARTNERSHIP TO DEVELOP COMPANION DIAGNOSTIC TEST FOR AZD9291 28 July 2014 AstraZeneca today announced it has entered into collaboration with Roche to develop a...

Alcon's Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease

Alcon's Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease Simbrinza provides a convenient option to reduce treatment burden versus...

Generic usage increased to more than 75% in 2013 according to NHS data

Generic usage increased to more than 75% in 2013 according to NHS data · £1.3bn additional cost savings for the NHS · Increased patient access to life saving...